The finding that the E6 protein from high-risk HPV can induce the degradation of p53 either in vitro or in vivo has led to the proposal that such an inactivation pathway could be involved in the neoplastic process leading to cervical cancer.3,10. This evidence concerns the gene TP53 and cervical cancer.